CHNA Holdings

CNCR

The China BioPharma ETF

ETF Information as of 12/17/2018

ETF Holdings

COMPANY NAME ↓ TICKER ↓ CUSIP ↓ SHARES ↓ MARKET VALUE ↓ % OF NET ASSETS ↓
SINOPHARM GROUP CO 1099 HK B3ZVDV0 28,000 $116,307.50 5.82%
AUSTAR LIFESCIENCE 6118 HK BSHYHZ4 136,000 $107,935.82 5.40%
SIHUAN PHARM HLDG 460 HK B4X3RF7 426,000 $96,520.12 4.83%
BEIGENE LTD BGNE 07725L102 708 $94,475.52 4.73%
WUXI BIOLOGICS (CA 2269 HK BZ3C3R5 13,000 $94,021.42 4.71%
HUTCHISON CHINA MEDITECH LTD SPONSORED ADR HCM 44842L103 2,757 $88,224.00 4.42%
ZAI LAB LTD ZLAB 98887Q104 3,856 $88,071.04 4.41%
SSY GROUP LIMITED 2005 HK BYP9J68 104,000 $86,000.47 4.30%
GUANGZHOU BAIYUNSH 874 HK 6084387 22,000 $84,344.06 4.22%
CHINA RES PHARM GR 3320 HK BYNGG26 60,000 $82,641.56 4.14%
SHANGHAI FOSUN PHA 2196 HK B8XBQ96 27,000 $82,603.16 4.13%
SHANGHAI PHARMACEU 2607 HK B4Q4CJ6 33,600 $73,719.96 3.69%
CSPC PHARMACEUTICA 1093 HK 6191997 48,000 $71,151.62 3.56%
CHINA BIOLOGIC PRODS HLDGS INC COM CBPO G21515104 916 $66,620.68 3.33%
CHINA GRAND PHARMA 512 HK B00W4D6 140,000 $65,949.40 3.30%
LUYE PHARMA GP LTD 2186 HK BNQ4GF3 93,000 $62,856.74 3.15%
SINO BIOPHARMACEUT 1177 HK B00XSF9 92,000 $61,827.56 3.09%
YICHANG HEC CHANGJ 1558 HK BYPHSW1 17,600 $61,730.28 3.09%
LIVZON PHARMACEUTI 1513 HK BJ34614 19,400 $59,600.23 2.98%
GENSCRIPT BIOTECH 1548 HK BD9Q2J2 40,000 $58,883.39 2.95%
SHANGHAI HAOHAI BI 6826 HK BWZN1R1 12,200 $55,752.33 2.79%
3SBIO INC 1530 HK BY9D3L9 41,000 $55,422.07 2.77%
CELLULAR BIOMEDICINE GROUP INC COM NEW CBMG 15117P102 2,904 $54,914.64 2.75%
LEES PHARMACEUTICA 950 HK BQZF1T7 66,000 $50,015.04 2.50%
ESSEX BIO-TECHNOLO 1061 HK 6370291 74,000 $47,457.45 2.38%
ASCLETIS PHARMA IN 1672 HK BFLTDL2 62,000 $47,618.74 2.38%
CHINA MEDICAL SYS 867 HK B6WY993 49,000 $46,729.09 2.34%
CASI PHARMACEUTICALS INC CASI 14757U109 8,508 $36,669.48 1.84%
Cash & Other Cash&Other Cash&Other -103.37 $-103.37 -0.01%
*ETF holdings and allocations are subject to change at any time and should not be interpreted as an offer of these securities